AB060. Long-term outcome following thulium vaporesection of the prostate
Printed Abstracts

AB060. Long-term outcome following thulium vaporesection of the prostate

Zhaocun Zhang, Benkang Shi

Department of Urology, Qilu Hospital of Shandong University, Jinan 250012, China


Background: To analyze the long-term outcomes after thulium vaporesection of the prostate (ThuVaRP).

Methods: ThuVaRP was performed with the 2-µm, continuous-wave, thulium: yttrium-aluminum-garnet laser, at 70-watt using the vaporesection technique (ThuVaRP). The perioperative and follow-up data were analyzed.

Results: Median operation time was 44.8±6.5 min, the mean hospital stay was 5.5±1.5 d. 36.24% patients had minor complications, while 0.15% patients got major ones. At discharge, Qmax, PVR volume, IPSS and QoL score were significantly improved and continued to do so at 3, 6, 12, 18, 24, 36, 48, 60 months follow-up.

Conclusions: Besides efficiency and safety ThuVaRP is also a durable procedure for the treatment of symptomatic benign prostatic obstruction (BPO), with low perioperative and late complications.

Keywords: Benign prostatic obstruction (BPO); long-term outcome; thulium vaporesection of the prostate (ThuVaRP); complication


doi: 10.21037/tau.2017.s060


Cite this abstract as: Zhang Z, Shi B. Long-term outcome following thulium vaporesection of the prostate. Transl Androl Urol 2017;6(Suppl 3):AB060. doi: 10.21037/tau.2017.s060

Download Citation